Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8058427 Coumarin compounds and their use for treating cancer

Patent 8058427 was granted and assigned to National Health Research Institutes on November, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

National Health Research Institutes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8058427

Patent Inventor Names

Jang-Yang Chang0

Ching-Chuan Kuo0

Hsing-Pang Hsieh0

Yu-Sheng Chao0

Date of Patent

November 15, 2011

Patent Application Number

12481783

Date Filed

June 10, 2009

Patent Citations Received

‌

US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

‌

US Patent 11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

‌

US Patent 11702412 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Patent Primary Examiner

‌

Rebecca Anderson

Patent abstract

Coumarin compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8058427 Coumarin compounds and their use for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API